01 7Zejula
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 470
2019 Revenue in Millions : 317
Growth (%) : 48
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 535
2020 Revenue in Millions : 464
Growth (%) : 17
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 571
2021 Revenue in Millions : 535
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 564
2022 Revenue in Millions : 571
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 93
2021 Revenue in Millions : 68
Growth (%) : 37
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 93
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 284
2018 Revenue in Millions : 0
Growth (%) : N/A
LOOKING FOR A SUPPLIER?